GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Syneos Health Inc. Class A Stock and on which exchange is it traded?
The symbol for Syneos Health Inc. Class A is SYNH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Syneos Health Inc. Class A Stock?
Syneos Health Inc. Class A holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Syneos Health Inc. Class A Stock?
Syneos Health Inc. Class A Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Syneos Health Inc. Class A Stock.

What's the current price of Syneos Health Inc. Class A Stock?
As of the end of day on the 2023-12-26, the price of an Syneos Health Inc. Class A (SYNH) share was $42.98.

What is the 52-week high and low for Syneos Health Inc. Class A Stock?
The 52-week high for Syneos Health Inc. Class A Stock is $43.35 and the 52-week low is $32.74.

What is the market capitalization of Syneos Health Inc. Class A Stock?
As of the 2023-12-26, the market capitalization of Syneos Health Inc. Class A is 4.458B.
Click to get the best stock tips daily for free!

About Syneos Health Inc. Class A

Syneos Health. Class A Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provide... SYNH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT